20-Jan-2022 - Bruker Corporation

Bruker Acquires Prolab Instruments

Augment Multiomics Solutions

Bruker Corporation announced the acquisition of Prolab Instruments GmbH, a Swiss technology company specialized in low-flow, high precision liquid chromatography technology and systems. Financial terms of the transaction were not disclosed.

Mr. Werner Doebelin, the Founder and CEO of Prolab, said: “We are pleased to become part of Bruker and augment the proteomics and metabolomics workflows of high-performance mass spectrometry systems like the timsTOF or scimaX® MRMS platforms. Our Zirconium pump is already part of the Bruker high-performance nanoElute system. Being part of Bruker allows us to increase the pace of product innovation, and we are looking forward to bringing our Mobile Injection Unit Technology to market to further improve performance and robustness in key applications, like single cell proteomics and lipidomics.”

Mr. Juergen Srega, the President of the Bruker CALID Group, explained: “Given the enormous sensitivity improvements of our timsTOF Pro 2 and timsTOF SCP mass spectrometers, our customers are working with lower and lower sample amounts. Prolab’s innovative mobile injector technology on the Zirconium Qube autosampler provides high-precision, low volume injections with minimal sample loss and carryover, as well as faster cycle times. Zirconium perfectly complements our ultra-high sensitivity unbiased, deep 4D proteomics, immunopeptidomics and single-cell proteomics solutions.”

Facts, background information, dossiers
  • AAS autosamplers
  • connectors
  • lipidomics
More about Bruker
  • News

    Bruker Appoints Philip Ma to its Board of Directors

    Bruker Corporation announced that its Board of Directors has appointed Philip Ma, Ph.D. to serve on its board, effective as of April 1, 2022. Dr. Ma is Chief Executive Officer, founder, and a director of PrognomiQ, a privately held healthcare company that is developing next-generation, tran ... more

    PreOmics announces early investors’ exit and closing of Series B financing

    PreOmics GmbH, a Martinsried, Germany-based developer of innovative automation and sample preparation tools and consumables for unbiased, deep proteomics analysis by mass spectrometry, has raised €13.5m in a Series B financing round provided by Bruker Corporation. PreOmics was founded in 20 ... more

    Bruker announces acquisition of a spin-off from Ghent University

    Bruker Corporation announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems. This acquisition strengthens Bruker’s position as a leading NMI solutions provider in preclinical and translational imaging research. The combin ... more

  • Companies

    Bruker BioSpin GmbH

    Leading manufacturer of NMR and EPR spectrometers. Comprehensive product offering covering the full range from purely routine instruments up to most advanced research systems. Optimized spectrometer configurations for metabolic and toxicological studies, as well as for structural proteomics ... more

    Bruker AXS GmbH

    Bruker AXS designs and manufactures analytical X-ray systems for elemental analysis, materials research and structural investigations. Our innovative solutions enable a wide range of customers in heavy industry, chemistry, pharmacy, semiconductor, life science and nanotechnology to make te ... more

    Bruker Corporation

    Bruker Corporation (NASDAQ: BRKR), Billerica, MA, is the parent of Bruker AXS, Bruker BioSpin, Bruker Daltonics., and Bruker Optics. Advanced X-ray systems do molecular and elemental analysis. Our spectrometers are used in life science, pharma, biochemical, chemical research, forensics, a ... more